advertisement
Goldberg I 39
Showing records 1 to 25 | Display all abstracts from Goldberg I70630 Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma
Zhou T
Molecular genetics & genomic medicine 2016; 4: 624-633
70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Skalicky SE
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166
70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Reis GM
Journal of Current Glaucoma Practice 2017; 11: 3-7
70044 Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma
Lusthaus JA
Expert Opinion on Investigational Drugs 2016; 25: 1201-1208
70791 Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals
Souzeau E
Ophthalmology 2017; 124: 303-309
70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
McAlinden C
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166
70791 Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals
Tram KH
Ophthalmology 2017; 124: 303-309
70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Grigg J
Journal of Current Glaucoma Practice 2017; 11: 3-7
70630 Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma
Souzeau E
Molecular genetics & genomic medicine 2016; 4: 624-633
70044 Investigational and experimental drugs for intraocular pressure reduction in ocular hypertension and glaucoma
Goldberg I
Expert Opinion on Investigational Drugs 2016; 25: 1201-1208
70791 Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals
Witney M
Ophthalmology 2017; 124: 303-309
70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Khatib T
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166
70630 Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma
Sharma S
Molecular genetics & genomic medicine 2016; 4: 624-633
70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Chua B
Journal of Current Glaucoma Practice 2017; 11: 3-7
70791 Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals
Ruddle JB
Ophthalmology 2017; 124: 303-309
70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Lee A
Journal of Current Glaucoma Practice 2017; 11: 3-7
70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Anthony LM
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166
70630 Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma
Siggs OM
Molecular genetics & genomic medicine 2016; 4: 624-633
70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Sim SY
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166
70630 Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma
Goldberg I
Molecular genetics & genomic medicine 2016; 4: 624-633
70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Lim R
Journal of Current Glaucoma Practice 2017; 11: 3-7
70791 Myocilin Predictive Genetic Testing for Primary Open-Angle Glaucoma Leads to Early Identification of At-Risk Individuals
Graham SL
Ophthalmology 2017; 124: 303-309
70630 Rare variants in optic disc area gene CARD10 enriched in primary open-angle glaucoma
Healey PR
Molecular genetics & genomic medicine 2016; 4: 624-633
70910 Incidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration
Higgins R
Journal of Current Glaucoma Practice 2017; 11: 3-7
70529 Activity Limitation in Glaucoma: Objective Assessment by the Cambridge Glaucoma Visual Function Test
Martin KR
Investigative Ophthalmology and Visual Science 2016; 57: 6158-6166
